Rovazolac is used in the pharmaceutical industry as an intermediate for synthesizing non-steroidal anti-inflammatory drugs (NSAIDs), particularly those with an oxazolidinone structure. It possesses analgesic, antipyretic, and anti-inflammatory effects, making it suitable for developing treatments for chronic pain conditions such as arthritis or muscle inflammation. It effectively inhibits the COX-2 enzyme and has fewer gastrointestinal side effects compared to other drugs in its class.